Financial Highlights - Li & Fung

Investors

Financial Highlights

 Continuing Operations#
Like-for-like*Reported
(US$ million)20172016 (Restated)**Change20172016 (Restated)**Change
Turnover13,53414,185(4.6%)13,53414,751(8.3%)
Total Margin
As % of Turnover
1,386
10.2%
1,408
9.9%
(1.5%)1,386
10.2%
1,495
10.1%
(7.3%)
Operating Costs As % of Turnover1,030
7.6%
1,094
7.7%
(5.8%)1,030
7.6%
1,177
8.0%
(12.4%)
Core Operating Profit
As % of Turnover
356
2.6%
314
2.2%
+13.3%356
2.6%
318
2.2%
+11.8%
Profit for the Year
- Continuing Operations
- Discontinued Operations
234
(543)
195
61
+19.7%
Profit attributable to shareholders****
- Continuing Operations
- Discontinued Operations
- Total
170
(545)
(375)
160
61
221
+6.5%
Earnings per Share from Continuing Operations - Basic (HK cents)
(equivalent to) (US cents)
15.8
2.04
14.9
1.92
Dividend per Share (HK cents)
- Interim
- Final
- Conditional Special Dividend
- Total
11
2
47.6
60.6
11
12
/
23.0
+163.5%
# Group results with Discontinued Operations separately presented given the strategic divestment of three Product Verticals announced in 2017
* Excluding the Asia consumer and healthcare distribution business, which was strategically divested in June 2016
** 2016 comparatives restated with adoption of New Accounting Standard HKFRS 15 (Note 1 to the financial information)
*** Excluding profit attributable to holders of perpetual capital securities and non-controlling interests

Turnover & Core Operating Profit

Like-for-like (Excluding the Asia consumer and healthcare distribution business, which was divested in June 2016
2017
2016
US$ 13,534
US$ 14,185M
Turnover
2017
2016
US$ 356M
US$ 314M
Core operating profit
Reported
2017
2016
US$ 13,534M
US$ 14,751M
Turnover
2017
2016
US$ 356M
US$ 318M
Core operating profit
Please download the latest “Acrobat Reader” to view the PDF.

Stay connected with us

Subscribe to our company news

IR contacts

please email us at: ir@lifung.com